440 related articles for article (PubMed ID: 17386401)
1. Duodenal-jejunal bypass for the treatment of type 2 diabetes in patients with body mass index of 22-34 kg/m2: a report of 2 cases.
Cohen RV; Schiavon CA; Pinheiro JS; Correa JL; Rubino F
Surg Obes Relat Dis; 2007; 3(2):195-7. PubMed ID: 17386401
[No Abstract] [Full Text] [Related]
2. Implantation of the duodenal-jejunal bypass sleeve under conscious sedation: a case series.
Montaña R; Slako M; Escalona A
Surg Obes Relat Dis; 2012; 8(5):e63-5. PubMed ID: 21955744
[No Abstract] [Full Text] [Related]
3. The effect of the endoscopic duodenal-jejunal bypass liner on obesity and type 2 diabetes mellitus, a multicenter randomized controlled trial.
Koehestanie P; de Jonge C; Berends FJ; Janssen IM; Bouvy ND; Greve JW
Ann Surg; 2014 Dec; 260(6):984-92. PubMed ID: 25072436
[TBL] [Abstract][Full Text] [Related]
4. Bariatric surgery in patients with morbid obesity and type 2 diabetes.
Schernthaner G; Morton JM
Diabetes Care; 2008 Feb; 31 Suppl 2():S297-302. PubMed ID: 18227500
[No Abstract] [Full Text] [Related]
5. [Surgical treatment of morbid obesity at a regional center].
Søvik TT; Aasheim ET; Kristinsson J; Schou CF; Nesbakken A; Mala T
Tidsskr Nor Laegeforen; 2007 Jan; 127(1):47-9. PubMed ID: 17205090
[TBL] [Abstract][Full Text] [Related]
6. Is reimplantation of the duodenal-jejunal bypass liner feasible?
Koehestanie P; Betzel B; Aarts EO; Janssen IM; Wahab P; Berends FJ
Surg Obes Relat Dis; 2015; 11(5):1099-104. PubMed ID: 25979208
[TBL] [Abstract][Full Text] [Related]
7. Total antioxidant status before and after bariatric surgery for type 2 diabetes mellitus.
Prior SL; Bain SC; Stephens JW; Alam I; Baxter JN
Metabolism; 2009 Sep; 58(9):1366; author reply 1367. PubMed ID: 19596373
[No Abstract] [Full Text] [Related]
8. ACP Journal Club: in obesity with type 2 diabetes, duodenal-jejunal bypass liners improved weight loss and HbA1c during treatment.
Cheskin LJ; Bloomberg School Of Public Health JH; Mullin GE
Ann Intern Med; 2015 Feb; 162(4):JC9. PubMed ID: 25686196
[No Abstract] [Full Text] [Related]
9. Initial human experience with restrictive duodenal-jejunal bypass liner for treatment of morbid obesity.
Escalona A; Yáñez R; Pimentel F; Galvao M; Ramos AC; Turiel D; Boza C; Awruch D; Gersin K; Ibáñez L
Surg Obes Relat Dis; 2010 Mar; 6(2):126-31. PubMed ID: 20359665
[TBL] [Abstract][Full Text] [Related]
10. Bariatric surgery for diabetes treatment: why should we go rapidly to surgery.
Laville M; Disse E
Diabetes Metab; 2009 Dec; 35(6 Pt 2):562-3. PubMed ID: 20152744
[TBL] [Abstract][Full Text] [Related]
11. Single-anastomosis duodenoileal bypass with sleeve gastrectomy (SADI-S) for obese diabetic patients.
Sánchez-Pernaute A; Rubio MÁ; Cabrerizo L; Ramos-Levi A; Pérez-Aguirre E; Torres A
Surg Obes Relat Dis; 2015; 11(5):1092-8. PubMed ID: 26048517
[TBL] [Abstract][Full Text] [Related]
12. Laparoscopic sleeve gastrectomy with duodeno-jejunal bypass for morbid obesity in a patient with situs inversus totalis.
Watanabe A; Seki Y; Kasama K
Asian J Endosc Surg; 2016 Aug; 9(3):218-21. PubMed ID: 27140835
[TBL] [Abstract][Full Text] [Related]
13. Laparoscopic sleeve gastrectomy with duodenojejunal bypass for severe obesity and/or type 2 diabetes may not require duodenojejunal bypass initially.
Gagner M
Obes Surg; 2010 Sep; 20(9):1323-4; author reply 1325-6. PubMed ID: 20411348
[No Abstract] [Full Text] [Related]
14. The duodenal-jejunal bypass sleeve (EndoBarrier Gastrointestinal Liner) for weight loss and treatment of type 2 diabetes.
Patel SR; Hakim D; Mason J; Hakim N
Surg Obes Relat Dis; 2013; 9(3):482-4. PubMed ID: 23452926
[TBL] [Abstract][Full Text] [Related]
15. Safety experience with the duodenal-jejunal bypass liner: an endoscopic treatment for diabetes and obesity.
Betzel B; Koehestanie P; Aarts EO; Dogan K; Homan J; Janssen IM; Wahab PJ; Groenen MJ; Berends FJ
Gastrointest Endosc; 2015 Nov; 82(5):845-52. PubMed ID: 25952090
[TBL] [Abstract][Full Text] [Related]
16. "Right-angled" stapled latero-lateral duodenojejunal anastomosis in the duodenal switch.
Sánchez-Pernaute A; Pérez-Aguirre E; Díez-Valladares L; Robin A; Talavera P; Rubio MA; Torres García A
Obes Surg; 2005 May; 15(5):700-2. PubMed ID: 15946463
[TBL] [Abstract][Full Text] [Related]
17. Comparative efficacy and safety of the duodenal-jejunal bypass liner in obese patients with type 2 diabetes mellitus: A case control study.
Laubner K; Riedel N; Fink K; Holl RW; Welp R; Kempe HP; Lautenbach A; Schlensak M; Stengel R; Eberl T; Dederichs F; Schwacha H; Seufert J; Aberle J
Diabetes Obes Metab; 2018 Aug; 20(8):1868-1877. PubMed ID: 29569313
[TBL] [Abstract][Full Text] [Related]
18. Consensus at last? The International Diabetes Federation statement on bariatric surgery in the treatment of obese Type 2 diabetes.
Pinkney J
Diabet Med; 2011 Aug; 28(8):884-5. PubMed ID: 21668496
[No Abstract] [Full Text] [Related]
19. Weight reduction and improvement in diabetes by the duodenal-jejunal bypass liner: a 198 patient cohort study.
Betzel B; Homan J; Aarts EO; Janssen IMC; de Boer H; Wahab PJ; Groenen MJM; Berends FJ
Surg Endosc; 2017 Jul; 31(7):2881-2891. PubMed ID: 27804045
[TBL] [Abstract][Full Text] [Related]
20. [Metabolic surgery].
Gaspari AL; Di Lorenzo N; Gentileschi P; Camperchioli I
G Chir; 2009 Apr; 30(4):133-40. PubMed ID: 19419612
[No Abstract] [Full Text] [Related]
[Next] [New Search]
